Richard Brown, MD
Hand Surgery · la Jolla, CANPI 1477571958
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (49.5%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by BD at 40.8% of the total. 2025 is the largest year on record at $1,084, 2.7 times the $405 reported in 2019.
Across 34 payments — averaging $73.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- BD$1K
- Lupin Inc.$500
- Endo Pharmaceuticals Inc.$499
- Anika Therapeutics, Inc.$106
- Ferring Pharmaceuticals Inc.$70
- Ensemble Orthopedics, Inc$59
- plus $257 from 9 others
What the payments were for
- Consulting fees$50020%
- Speaking & faculty fees$1,24550%
- Food & beverage$77031%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| BD | 2 | $1,025 |
| Lupin Inc. | 1 | $500 |
| Endo Pharmaceuticals Inc. | 15 | $499 |
| Anika Therapeutics, Inc. | 1 | $106 |
| Ferring Pharmaceuticals Inc. | 1 | $70 |
| Ensemble Orthopedics, Inc | 1 | $59 |
| Acumed LLC | 2 | $51 |
| Zimmer Biomet | 2 | $49 |
| Pacira Therapeutics, Inc. | 2 | $37 |
| Stryker | 2 | $32 |
| Integra Lifesciences Corporation | 1 | $21 |
| Elevate Surgical Co | 1 | $18 |
| Nalu Medical, Inc. | 1 | $17 |
| Smith+Nephew | 1 | $17 |
| Axogen | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,515 in reported general payments places this provider in the 55th percentile of 249 hand surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 24 | $1,248 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 167 | $944 |
Paid to pharmacies, not to this prescriber.
Other hand surgery in la Jolla
- Lorenzo Pacellila Jolla$46K
- Steven ShinLos Angeles$2.8M
- Amy LaddStanford$1.4M
- Emilie CheungStanford$1.1M
- Andrew HartmanOceanside$957K
- Nancy LynchSan Mateo$862K
- Jeffrey YaoRedwood City$622K
- Prosper BenhaimLos Angeles$492K
- Wayne PanOakland$423K
- Nathan HoekzemaClovis$400K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.